Headline
The latest stories from AHA Today.
The AHA released the latest edition of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
The AHA continues to spotlight the important work of rural hospitals tasked with caring for the nearly 60 million Americans who live in rural communities.
The Food and Drug Administration and Magellan Diagnostics Inc. expanded the ongoing recall of LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests distributed between Oct. 27, 2020, and Aug. 19, 2021.
The AHA launched a new video series, Vaccines Work, highlighting all the successful vaccines that have helped fight severe disease and illness, such as polio, mumps and tetanus
Five Los Angeles County health care organizations — Providence, UCLA Health, Keck Medicine of USC, Dignity Health and Cedars-Sinai — have unveiled a campaign urging their community to seek timely access to medical assistance.
Depression during pregnancy and postpartum depression are among the most common complications of pregnancy, even higher than hypertension and diabetes, said Alpa Shah, M.D., director of the Perinatal Mental Health Clinic at Marshfield Clinic Health System.
A new study released by the National Academies of Sciences, Engineering and Medicine offers advice for communicating with parents about their children’s COVID-19 vaccination, along with strategies for building public confidence in the vaccines
Food and Drug Administration staff provided their analysis of Johnson & Johnson’s COVID-19 booster application, indicating that a second dose provides substantially more protection against SAR-CoV-2 than the initial shot.
In this Advancing Health podcast, hear from Matthew Simpson, vice president of system support services at Indiana University Health, and Curtis Correll, vice president of operations at Aramark, as they tell the story of how Indiana University Health was able to achieve and deliver on a successful,…
The Food and Drug Administration announced it will withdraw regulations for non-drug manufacturers who produced during the COVID-19 public health emergency alcohol-based hand sanitizer or alcohol for use in hand sanitizers.